0000874015-22-000070.txt : 20220202 0000874015-22-000070.hdr.sgml : 20220202 20220202192614 ACCESSION NUMBER: 0000874015-22-000070 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220131 FILED AS OF DATE: 20220202 DATE AS OF CHANGE: 20220202 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Baroldi Joseph CENTRAL INDEX KEY: 0001813775 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19125 FILM NUMBER: 22585856 MAIL ADDRESS: STREET 1: C/O AVIDITY BIOSCIENCES, INC. STREET 2: 10975 N. TORREY PINES RD., SUITE 150 CITY: LA JOLLA STATE: CA ZIP: 92037 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IONIS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000874015 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330336973 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 BUSINESS PHONE: 7609319200 MAIL ADDRESS: STREET 1: 2855 GAZELLE COURT CITY: CARLSBAD STATE: CA ZIP: 92010 FORMER COMPANY: FORMER CONFORMED NAME: ISIS PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2022-01-31 0 0000874015 IONIS PHARMACEUTICALS INC IONS 0001813775 Baroldi Joseph 2855 GAZELLE COURT CARLSBAD CA 92010 0 1 0 0 Chief Business Officer Non-Qualified Stock Option (right to buy) 31.8 2022-01-31 2022-01-31 4 A 0 86700 0.0 A 2023-01-31 2032-01-30 Common Stock 86700 86700 D Grant on 01/31/2022 to reporting person of stock options under the Ionis Pharmaceuticals, Inc. Amended and Restated 2011 Equity Incentive Plan. Following this transaction, the option was exercisable as to 0 shares on 01/31/2022. 25% of the shares subject to the option will vest and become exercisable on 01/31/2023. Thereafter, the remaining shares subject to the option will vest and become exercisable in 36 equal monthly installments over the next 3 years. By: Patrick R. O'Neil, attorney-in-fact For: Joseph T. Baroldi 2022-02-01